Michael Stover, MD
Orthopaedic Surgery · Chicago, ILNPI 1033183363
Payments from drug & device makers
Across 96 payments — averaging $742.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$49K
- Medical Device Business Services, Inc.$11K
- Osteocentric Technologies, Inc.$5K
- Depuy Synthes Products, Inc.$4K
- Lightbody Medical Technologies Inc$2K
- Arthrex$418
- plus $456 from 5 others
What the payments were for
- Consulting fees$12,92318%
- Speaking & faculty fees$31,83145%
- Travel & lodging$23,92034%
- Food & beverage$2,6134%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 51 | $48,604 |
| Medical Device Business Services, Inc. | 9 | $11,351 |
| Osteocentric Technologies, Inc. | 18 | $4,976 |
| Depuy Synthes Products, Inc. | 1 | $3,803 |
| Lightbody Medical Technologies Inc | 5 | $1,678 |
| Arthrex | 3 | $418 |
| Smith+Nephew | 2 | $206 |
| Stryker | 3 | $160 |
| Medacta USA, Inc. | 1 | $56 |
| Johnson & Johnson | 2 | $27 |
| Orthofix Medical, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CORAIL$9,120
- PINNACLE$6,030
- OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST$4,577
- ACTIS$1,983
- HEALICOIL Suture Anchor$112
- Q-FIX Hip$112
- NAVIO$112
- LENS 4K$112
How this compares
$71,286 in reported general payments places this provider in the 85th percentile of 844 orthopaedic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 56 | $273 |
| Cephalexin | 34 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Chicago
- Aaron RosenbergChicago$12.4M
- Anish KadakiaChicago$2.1M
- Wellington HsuChicago$1.7M
- Ken YamaguchiChicago$1.7M
- Guido MarraChicago$1.2M
- Hue LuuChicago$1.1M
- Alpesh PatelChicago$960K
- Samuel StulbergChicago$852K
- John SonnenbergChicago$711K
- Peter SmithChicago$710K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.